Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Sehgal

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Experimental Pharmacology|October 29, 2021
Preclinical Efficacy and Safety Studies of Formulation SSV-003, a Potent Anti-Viral Herbal FormulationYogesh Arun Dound, Rajesh Sehgal
Rare Tumors|November 2, 2013
A Case of Small Cell Cancer of the Breast in a Male with Synchronous Stage IV Non-Small Cell Lung CarcinomaLaurie Matt, Teresa Limjoco, Rajesh Sehgal
International Journal of Biomedical Science : IJBS|May 16, 2013
A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination)Anupama Tamta, Manu Chaudhary, Rajesh Sehgal
BMC Complementary and Alternative Medicine|September 20, 2005
Evaluation of antimotility effect of Lantana camara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in miceLenika Sagar, Rajesh Sehgal, Sudarshan Ojha
Cancer Investigation|October 12, 2010
Prevention of breast cancer (Part II): risk reduction strategiesMaria Tria Tirona, Rajesh Sehgal, Oscar Ballester
Current Clinical Pharmacology|January 20, 2009
Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infectionsManu Chaudhary, Sanjay Mohan Shrivastava, Rajesh Sehgal
Cancer Investigation|July 20, 2010
Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment toolsMaria Tria Tirona, Rajesh Sehgal, Oscar Ballester
Current Drug Safety|August 12, 2008
Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infectionsManu Chaudhary, Sanjay Mohan Shrivastava, Rajesh Sehgal
Journal of Clinical Medicine|February 10, 2019
Chimeric Antigen Receptor T-Cells: The Future is NowWassim Mchayleh, Prabhjot Bedi, Rajesh Sehgal, et al.
Current Clinical Pharmacology|August 15, 2008
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patientsManu Chaudhary, Sanjay Mohan Shrivastava, Lallu Varughese, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Experimental Pharmacology|October 29, 2021
Preclinical Efficacy and Safety Studies of Formulation SSV-003, a Potent Anti-Viral Herbal FormulationYogesh Arun Dound, Rajesh Sehgal
Rare Tumors|November 2, 2013
A Case of Small Cell Cancer of the Breast in a Male with Synchronous Stage IV Non-Small Cell Lung CarcinomaLaurie Matt, Teresa Limjoco, Rajesh Sehgal
International Journal of Biomedical Science : IJBS|May 16, 2013
A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination)Anupama Tamta, Manu Chaudhary, Rajesh Sehgal
BMC Complementary and Alternative Medicine|September 20, 2005
Evaluation of antimotility effect of Lantana camara L. var. acuelata constituents on neostigmine induced gastrointestinal transit in miceLenika Sagar, Rajesh Sehgal, Sudarshan Ojha
Cancer Investigation|October 12, 2010
Prevention of breast cancer (Part II): risk reduction strategiesMaria Tria Tirona, Rajesh Sehgal, Oscar Ballester
Current Clinical Pharmacology|January 20, 2009
Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infectionsManu Chaudhary, Sanjay Mohan Shrivastava, Rajesh Sehgal
Cancer Investigation|July 20, 2010
Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment toolsMaria Tria Tirona, Rajesh Sehgal, Oscar Ballester
Current Drug Safety|August 12, 2008
Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infectionsManu Chaudhary, Sanjay Mohan Shrivastava, Rajesh Sehgal
Journal of Clinical Medicine|February 10, 2019
Chimeric Antigen Receptor T-Cells: The Future is NowWassim Mchayleh, Prabhjot Bedi, Rajesh Sehgal, et al.
Current Clinical Pharmacology|August 15, 2008
Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patientsManu Chaudhary, Sanjay Mohan Shrivastava, Lallu Varughese, et al.
Pageof 2